Evidence map›Paper›PMID 34575515›Full record

ArticlePharmaceutics2021

Chitin Nanofibril Application in Tympanic Membrane Scaffolds to Modulate Inflammatory and Immune Response.

Serena Danti, Shivesh Anand, Bahareh Azimi, Mario Milazzo, Alessandra Fusco, Claudio Ricci, Lorenzo Zavagna, Stefano Linari, Giovanna Donnarumma, Andrea Lazzeri and 3 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Serena DantiInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0002-8155-8537
Shivesh AnandDepartment of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0001-9662-2039
Bahareh AzimiInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.
Mario MilazzoInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0001-8429-5544
Alessandra FuscoInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0003-2641-1070
Claudio RicciInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.
Lorenzo ZavagnaInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0003-2900-2694
Stefano LinariLinari Engineering s.r.l., 56121 Pisa, Italy.
Giovanna DonnarummaInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0002-3087-1240
Andrea LazzeriInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.ORCID 0000-0002-9463-1502
Lorenzo MoroniDepartment of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0003-1298-6025
Carlos MotaDepartment of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0001-5935-6245
Stefano BerrettiniInteruniversity National Consortiums of Materials Science and Technology (INSTM), 50121 Firenze, Italy.

Funding

European Commission ERA-NET cofund, EuroNanoMed III, project 4NanoEARDRMMinistero dell'Istruzione, dell'Università e della Ricerca B56H18000140001Nederlandse Organisatie voor Wetenschappelijk Onderzoek OND1365231
6 · The paper itself

Abstract

Chitin nanofibrils (CNs) are an emerging bio-based nanomaterial. Due to nanometric size and high crystallinity, CNs lose the allergenic features of chitin and interestingly acquire anti-inflammatory activity. Here we investigate the possible advantageous use of CNs in tympanic membrane (TM) scaffolds, as they are usually implanted inside highly inflamed tissue environment due to underlying infectious pathologies. In this study, the applications of CNs in TM scaffolds were twofold. A nanocomposite was used, consisting of poly(ethylene oxide terephthalate)/poly(butylene terephthalate) (PEOT/PBT) copolymer loaded with CN/polyethylene glycol (PEG) pre-composite at 50/50 (

Indexed as

anti-inflammatorybiodegradationdefensineardrum perforationelectrospinningelectrospraykeratinocytesmushroomnanocompositepolyethylene oxide terephthalate polybutylene terephthalate (PEOT/PBT)shrimptympanoplasty

Identifiers

PMID34575515
PMCPMC8468799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.